Aberrant immunophenotypic expressions in childhood acute leukemias: A tertiary care hospital experience
- PMID: 40103873
- PMCID: PMC11911744
- DOI: 10.12669/pjms.41.3.9717
Aberrant immunophenotypic expressions in childhood acute leukemias: A tertiary care hospital experience
Abstract
Background & objective: Pediatric acute leukemias can present with aberrant immunophenotypes characterized by a different pattern of antigen expression on malignant cells, unlike the process of usual hematopoietic maturation. The objective of this study was to determine the aberrant immunophenotype expressions in newly diagnosed pediatric acute lymphoblastic and acute myeloid leukemias.
Methods: This cross-sectional study was carried out at University of Child Health Sciences, The Children's Hospital, Lahore, from October 2022 to December 2022 after IRB approval. After taking informed consent from parents/guardians, 290 children diagnosed with acute leukemia were included in the study. Peripheral blood or bone marrow samples in EDTA vial were used for flowcytometric analysis by using BD FACS Canto II flow-cytometer. The data was collected on a pre-designed proforma and analyzed by using IBM-SPSS V-23.
Result: Among 290 cases, Acute Lymphoblastic Leukemia (ALL) constituted 221(76.2%) cases and 69(23.7%) were Acute Myeloid Leukemia (AML). Out of the total, the aberrant antigens were present in 32(11%) patients with 40 total events (18.1% immunophenotype aberrancy rate). The most common aberrant antigens were reported in B-ALL and the most common aberrant expression was of CD13 (62.5%). In AML, the most common aberrant antigen seen was CD19 (55.6%) and in T-ALL the most common were CD117 and HLA-DR (26.6%).
Conclusion: The most aberrant immunophenotypic markers were seen mostly in B-ALL pediatric cases followed by AML and T-ALL. Such abnormal expressions should be kept in mind while diagnosing the children with acute leukemia as they may affect the prognosis.
Keywords: Aberrant markers; Acute leukemia; Children; Immunophenotypic expression; Minimal Residual Disease.
Copyright: © Pakistan Journal of Medical Sciences.
Figures
Similar articles
-
--Immunophenotypic Aberrancies in Acute Leukemia: A Tertiary Care Centre Experience.Oman Med J. 2021 Jan 31;36(1):e218. doi: 10.5001/omj.2021.03. eCollection 2021 Jan. Oman Med J. 2021. PMID: 33585041 Free PMC article.
-
Spectrum and Immunophenotypic Profile of Acute Leukemia: A Tertiary Center Flow Cytometry Experience.Mediterr J Hematol Infect Dis. 2019 Mar 1;11(1):e2019017. doi: 10.4084/MJHID.2019.017. eCollection 2019. Mediterr J Hematol Infect Dis. 2019. PMID: 30858955 Free PMC article.
-
Characterization of Immunophenotypic Aberrancies with Respect to Common Fusion Transcripts in B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 986 Indian Patients.Turk J Haematol. 2022 Feb 23;39(1):1-12. doi: 10.4274/tjh.galenos.2021.2021.0326. Epub 2021 Oct 7. Turk J Haematol. 2022. PMID: 34617433 Free PMC article.
-
[Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].Folia Med Cracov. 2001;42(3):5-80. Folia Med Cracov. 2001. PMID: 12353422 Review. Polish.
-
Definition of acute biphenotypic leukemia.Haematologica. 1997 Jan-Feb;82(1):64-6. Haematologica. 1997. PMID: 9107085 Review.
References
-
- Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Switzerland: World Health Organization Press; 2017. pp. 168–178.
-
- Vora A. Childhood acute lymphoblastic leukaemia. In: Hoffbrand AV, Higgs DR, Keeling DM, Mehta AB, editors. Postgrad Haematol. 7th edition. Vol. 22. UK: Wiley Blackwell Publishing; 2016. pp. 384–398.
-
- Morilla R, Morilla AM, Nadal-Melsió E. Immunophenotyping by flow cytometry. In: Bain BJ, Bates I, Laffan MA, editors. Dacie Lewis Pract Haematol. 12th edition. Vol. 16. Philadelphia: Elsevier Limited; 2017. pp. 330–349.
-
- Mohamed MA, Shafik EA, Ahmed AO, Sayed DM. Expression of aberrant markers in acute leukemia at south Egypt cancer institute:A retrospective study. SECI Oncol. 2021;9:53–63.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous